Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 18 April 2003:
Vol. 300. no. 5618, pp. 413 - 414
DOI: 10.1126/science.300.5618.413
Prev | Table of Contents | Next

News Focus

INFECTIOUS DISEASES:
Calling All Coronavirologists

Martin Enserink

The ongoing epidemic of acute respiratory disease is shining an intense spotlight on one of virology's backwaters.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3).
C.-N. Chen, C. P. C. Lin, K.-K. Huang, W.-C. Chen, H.-P. Hsieh, P.-H. Liang, and J. T.-A. Hsu (2005)
Evid. Based Complement. Altern. Med. 2, 209-215
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)